Showing 1-10 of 42 results

Zeroing in on Therapeutic Drug Targets

https://www.biomarin.com/our-science/spotlight/zeroing-in-on-therapeutic-drug-targets/

In their groundbreaking Nature Communications paper, scientific pioneers Lon Cardon and Karol Estrada shed new light on the decades-old question of how to identify optimal drug targets

2025 Focus Area

https://www.biomarin.com/our-company/corporate-social-responsibility/diversity-equity-inclusion/2025-focus-area/

Learning and Development

https://www.biomarin.com/our-company/corporate-social-responsibility/diversity-equity-inclusion/development-and-learning/

Clinical Trial Diversity

https://www.biomarin.com/our-company/corporate-social-responsibility/diversity-equity-inclusion/clinical-trial-diversity/

Maintain Full Pay Equity in U.S. and Increase to Fullest Extent Globally

https://www.biomarin.com/our-company/corporate-social-responsibility/diversity-equity-inclusion/expand-base-pay-equity/

Company Milestones

https://www.biomarin.com/our-company/about-us/company-milestones/

Read through the history, achievements, and milestones of BioMarin.

Privacy Policy

https://www.biomarin.com/privacy-policy/

BioMarin does not sell your personal information. Please visit the page to understand the privacy policy and cookies functionality fully.

In the Hemophilia Community

https://www.biomarin.com/our-motivation/patient-and-community-support/in-the-hemophilia-community/

Know the achievements of our Hemophilia Community of patients and caregivers through arts and self-expression.

Supplier Information

https://www.biomarin.com/supplier-information/

Please review the supplier information for all purchase order guidelines.

Annabelle

https://www.biomarin.com/our-motivation/patient-stories/annabelle/

Read the story of MPS IVA patient, Annabelle affected by rare genetic disease. Know the struggle, fight & willingness to tackle.